Denise M. Pothier

Array ( [id] => 6856784 [patent_doc_number] => 20030130285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases' [patent_app_type] => new [patent_app_number] => 10/317464 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22383 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130285.pdf [firstpage_image] =>[orig_patent_app_number] => 10317464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236018 [patent_doc_number] => 06689772 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => '3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors' [patent_app_type] => B1 [patent_app_number] => 10/318213 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 97481 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 3769 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689772.pdf [firstpage_image] =>[orig_patent_app_number] => 10318213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865607 [patent_doc_number] => 20030191133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Indole derivatives useful for the treatment of CNS disorders' [patent_app_type] => new [patent_app_number] => 10/315927 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15659 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191133.pdf [firstpage_image] =>[orig_patent_app_number] => 10315927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683857 [patent_doc_number] => 20030119721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Electrophilic ketones for the treatment of herpesvirus infections' [patent_app_type] => new [patent_app_number] => 10/303596 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14522 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119721.pdf [firstpage_image] =>[orig_patent_app_number] => 10303596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059621 [patent_doc_number] => 06852711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-08 [patent_title] => 'HIV protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/299510 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55679 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852711.pdf [firstpage_image] =>[orig_patent_app_number] => 10299510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1264985 [patent_doc_number] => 06660728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-09 [patent_title] => 'Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists' [patent_app_type] => B2 [patent_app_number] => 10/368771 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22459 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 613 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660728.pdf [firstpage_image] =>[orig_patent_app_number] => 10368771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150385 [patent_doc_number] => 06770639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Heterocyclic compounds useful as inhibitors of tyrosine kinases' [patent_app_type] => B2 [patent_app_number] => 10/292026 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28027 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770639.pdf [firstpage_image] =>[orig_patent_app_number] => 10292026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278693 [patent_doc_number] => 06645956 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Heteroaromatic derivatives having an inhibitory activity against HIV integrase' [patent_app_type] => B1 [patent_app_number] => 10/288380 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 136883 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645956.pdf [firstpage_image] =>[orig_patent_app_number] => 10288380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1196971 [patent_doc_number] => 06727237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-27 [patent_title] => 'Inhibitors of bacterial NAD synthetase' [patent_app_type] => B2 [patent_app_number] => 10/281407 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33293 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727237.pdf [firstpage_image] =>[orig_patent_app_number] => 10281407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368223 [patent_doc_number] => 20040006107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity' [patent_app_type] => new [patent_app_number] => 10/279231 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70414 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006107.pdf [firstpage_image] =>[orig_patent_app_number] => 10279231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355553 [patent_doc_number] => 20040048868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Benzimidazoles' [patent_app_type] => new [patent_app_number] => 10/279834 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 155545 [patent_no_of_claims] => 194 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048868.pdf [firstpage_image] =>[orig_patent_app_number] => 10279834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093138 [patent_doc_number] => 06825184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => '1,4-Disubstituted benzo-fused urea compounds' [patent_app_type] => B2 [patent_app_number] => 10/269173 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16634 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825184.pdf [firstpage_image] =>[orig_patent_app_number] => 10269173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1256362 [patent_doc_number] => 06667304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-23 [patent_title] => 'Polycyclic azaindole compounds' [patent_app_type] => B2 [patent_app_number] => 10/267238 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14372 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 502 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667304.pdf [firstpage_image] =>[orig_patent_app_number] => 10267238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683954 [patent_doc_number] => 20030119818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'CRF antagonistic quino-and quinazolines' [patent_app_type] => new [patent_app_number] => 10/266662 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7934 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119818.pdf [firstpage_image] =>[orig_patent_app_number] => 10266662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683964 [patent_doc_number] => 20030119828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Substituted guanidine derivatives' [patent_app_type] => new [patent_app_number] => 10/261855 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9887 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119828.pdf [firstpage_image] =>[orig_patent_app_number] => 10261855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1303882 [patent_doc_number] => 06620840 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them' [patent_app_type] => B1 [patent_app_number] => 10/255849 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18737 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 478 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620840.pdf [firstpage_image] =>[orig_patent_app_number] => 10255849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818464 [patent_doc_number] => 20030069422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof' [patent_app_type] => new [patent_app_number] => 10/253029 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6547 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069422.pdf [firstpage_image] =>[orig_patent_app_number] => 10253029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369464 [patent_doc_number] => 20040092737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Benzopiperidine derivatives' [patent_app_type] => new [patent_app_number] => 10/247310 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 271037 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092737.pdf [firstpage_image] =>[orig_patent_app_number] => 10247310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 720183 [patent_doc_number] => 07049306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.' [patent_app_type] => utility [patent_app_number] => 10/251442 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66106 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049306.pdf [firstpage_image] =>[orig_patent_app_number] => 10251442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822177 [patent_doc_number] => 20030220338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Fungal efflux pump inhibitors' [patent_app_type] => new [patent_app_number] => 10/243074 [patent_app_country] => US [patent_app_date] => 2002-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15396 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220338.pdf [firstpage_image] =>[orig_patent_app_number] => 10243074 [rel_patent_id] =>[rel_patent_doc_number] =>)